Search | Page 39 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Resistance to Hypomethylating Agents in the Treatment of MDS

    ... to 60% to 80% overall response rates for MDS patients in clinical trials. But that still means about 25% or more patients are ... hypothesis in a prospective manner will help support this research and may help us direct therapeutic choices for our future patients. ...

    Interview last updated 06/17/2014 - 9:15am.

  2. Nurses' Corner January 2015: Talking about Hope with Patients

    ... If it is indeed a lifeline, where is it in our clinical care?  How and when are we addressing it?   Ask your patient ... answers may surprise you.   Anna Ferguson RN, BSN Research Nurse, Department of Hematologic Malignancies Founder and Director, ...

    Page last updated 01/27/2015 - 10:43am.

  3. Kim-Hien T. Dao, DO, PhD

    ... anemia core complex Original Research Center:  Oregon Health & Science University ... leukemia . She works with other scientists on several clinical trials (research studies), and plans to start her own clinical trials ...

    Grant Recipient last updated 10/01/2012 - 10:46am.

  4. Mridul Mukherji, DPhil

    ... from MDS Patients Original Research Center:  University of Missouri - Kansas City ... have made significant progress in developing a library of clinical samples which can be used to observe and rescue the activity of some ...

    Grant Recipient last updated 10/01/2012 - 10:46am.

  5. Lower-Risk MDS: Diagnosis and Treatment Options

    ... will be considered. It is also important in designing clinical trials and applying the results of clinical trials. We do not take ... shorten life rather than lengthen it. One very important research study looked at transplant outcomes in patients in each of the IPSS ...

    Interview last updated 05/18/2012 - 1:28pm.

  6. Zhe Yang, PhD

    ... DNA demethylation in MDS Original Research Center:  Wayne State University ... myelodysplastic syndromes (MDS) highlights the clinical significance of this myeloid relevant protein with potential ...

    Grant Recipient last updated 12/06/2013 - 4:25pm.

  7. North American Pediatric Aplastic Anemia Consortium Symposium

    ...  As with all rare diseases, there is a relative lack of research to develop cures and guide the management of affected patients. The ... of Philadelphia) discussed outcomes data essential to clinical decision-making. The current overall survival for matched sibling ...

    Page last updated 10/31/2013 - 4:06pm.

  8. Neal Young, M.D., MACP

    ... / Title:  Chief of the Intramural Research Hematology Branch, National Heart, Lung, and Blood Institute, National ... instability. His research includes direct patient care and clinical protocols for the treatment of bone marrrow failure; basic science ...

    Leadership Award last updated 07/19/2012 - 11:34am.

  9. Casey O’Connell, MD

    ... University of Southern California (USC). In addition to her clinical work with patients at the Norris Comprehensive Cancer Center, she conducts clinical and translational research in Myeloproliferative and Myelodysplastic Syndromes (MDS). She ...

    Page last updated 04/18/2012 - 1:47pm.

  10. Treating Higher-Risk Myelodysplastic Syndromes

    ... would be the hypomethlating agents mentioned earlier. Clinical trials are also an important component to patient care if there is ... decitabine, or lenalidomide (Revlimid®). Clinical research with new chemotherapy combinations are the key to improving therapy ...

    Interview last updated 05/18/2012 - 1:55pm.